Cargando…

Deep Brain Stimulation Selection Criteria for Parkinson’s Disease: Time to Go beyond CAPSIT-PD

Despite being introduced in clinical practice more than 20 years ago, selection criteria for deep brain stimulation (DBS) in Parkinson’s disease (PD) rely on a document published in 1999 called ‘Core Assessment Program for Surgical Interventional Therapies in Parkinson’s Disease’. These criteria are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Artusi, Carlo Alberto, Lopiano, Leonardo, Morgante, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761824/ https://www.ncbi.nlm.nih.gov/pubmed/33291579 http://dx.doi.org/10.3390/jcm9123931

Ejemplares similares

Should we offer deep brain stimulation to Parkinson’s disease patients with GBA mutations?
por: Artusi, Carlo Alberto, et al.
Publicado: (2023)

Deep Brain Stimulation Outcomes in Parkinson's Disease Patients with Cognitive Impairment: Implications and Considerations
por: Romagnolo, Alberto, et al.
Publicado: (2023)

Criteria for identification of advanced Parkinson’s disease: the results of the Italian subgroup of OBSERVE-PD observational study
por: Stefani, Alessandro, et al.
Publicado: (2022)

Safety and efficacy of tolcapone in Parkinson’s disease: systematic review
por: Artusi, Carlo Alberto, et al.
Publicado: (2021)

Pisa Syndrome in Parkinson's Disease Is Associated With Specific Cognitive Alterations
por: Artusi, Carlo Alberto, et al.
Publicado: (2019)

COVID-19 in Parkinson's disease: Report on prevalence and outcome
por: Artusi, Carlo Alberto, et al.
Publicado: (2020)

Assessment of Axial Postural Abnormalities in Parkinsonism: Automatic Picture Analysis Software
por: Artusi, Carlo Alberto, et al.
Publicado: (2023)

COVID-19 and Parkinson’s Disease: What Do We Know So Far?
por: Artusi, Carlo Alberto, et al.
Publicado: (2021)

Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease
por: Montanaro, Elisa, et al.
Publicado: (2021)

SARS-CoV-2 vaccination, Parkinson’s disease, and other movement disorders: case series and short literature review
por: Imbalzano, Gabriele, et al.
Publicado: (2022)

Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis
por: Artusi, Carlo Alberto, et al.
Publicado: (2019)

Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic
por: Montanaro, Elisa, et al.
Publicado: (2021)

Camera- and Viewpoint-Agnostic Evaluation of Axial Postural Abnormalities in People with Parkinson’s Disease through Augmented Human Pose Estimation
por: Aldegheri, Stefano, et al.
Publicado: (2023)

Impulsivities and Parkinson's Disease: Delay Aversion Is Not Worsened by Deep Brain Stimulation of the Subthalamic Nucleus
por: Torta, Diana M. E., et al.
Publicado: (2012)

Deep Brain Stimulation of the subthalamic nucleus does not negatively affect social cognitive abilities of patients with Parkinson’s disease
por: Enrici, Ivan, et al.
Publicado: (2017)

Burden of caregiving for cardiovascular dysautonomia in Parkinson’s disease
por: Ledda, Claudia, et al.
Publicado: (2022)

Longitudinal Assessment of Botulinum Toxin Treatment for Lateral Trunk Flexion and Pisa Syndrome in Parkinson’s Disease: Real-life, Long-Term Study
por: Ledda, Claudia, et al.
Publicado: (2023)

The Dominant-Subthalamic Nucleus Phenomenon in Bilateral Deep Brain Stimulation for Parkinson’s Disease: Evidence from a Gait Analysis Study
por: Rizzone, Mario Giorgio, et al.
Publicado: (2017)

Time to onset and duration of botulinum toxin efficacy in movement disorders
por: Ledda, Claudia, et al.
Publicado: (2022)

Efficacy of amantadine in patients hospitalized with COVID-19: Study protocol of a randomized, double-blind, placebo-controlled trial
por: Lopiano, Leonardo, et al.
Publicado: (2021)

How resistant are levodopa‐resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease
por: Imbalzano, Gabriele, et al.
Publicado: (2022)

Square Biphasic Pulse Deep Brain Stimulation for Parkinson’s Disease: The BiP-PD Study
por: De Jesus, Sol, et al.
Publicado: (2019)

Task Force Consensus on Nosology and Cut‐Off Values for Axial Postural Abnormalities in Parkinsonism
por: Tinazzi, Michele, et al.
Publicado: (2022)

COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features
por: Antonini, Angelo, et al.
Publicado: (2008)

Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria
por: Fu, Marcela, et al.
Publicado: (2018)

Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson’s and Alzheimer’s Disease Therapy
por: Senevirathne, Degiri Kalana Lasanga, et al.
Publicado: (2023)

Going Deep: The Role of Neural Networks for Renal Survival and Beyond
por: Averitt, Amelia J., et al.
Publicado: (2018)

Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI
por: Marona, Jose, et al.
Publicado: (2020)

Beta-triggered adaptive deep brain stimulation during reaching movement in Parkinson’s disease
por: He, Shenghong, et al.
Publicado: (2023)

In Parkinson’s disease on a probabilistic Go/NoGo task deep brain stimulation of the subthalamic nucleus only interferes with withholding of the most prepotent responses
por: Georgiev, Dejan, et al.
Publicado: (2016)

Update on deep brain stimulation in Parkinson’s disease
por: Martinez-Ramirez, Daniel, et al.
Publicado: (2015)

Gender influence on selection and outcome of deep brain stimulation for Parkinson's disease
por: Chandran, Shyambabu, et al.
Publicado: (2014)

Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients
por: Fasano, Alfonso, et al.
Publicado: (2019)

Embeddings from deep learning transfer GO annotations beyond homology
por: Littmann, Maria, et al.
Publicado: (2021)

The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's Disease
por: Abbruzzese, Giovanni, et al.
Publicado: (2021)

Go beyond Hubble and go deeper in the universe
por: Li, Haining
Publicado: (2022)

Cohort study of neurological comorbidities and COVID-19-related case fatality
por: Imbalzano, Gabriele, et al.
Publicado: (2021)

Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild COVID-19 infection
por: Piazza, Federico, et al.
Publicado: (2021)

Meropenem PK/PD Variability and Renal Function: “We Go Together”
por: Angelini, Jacopo, et al.
Publicado: (2023)

Neuropsychological profile of Parkinson's disease patients selected for deep brain stimulation surgery
por: Machado, Flavia Amaral, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_g2t5dte1jda3rldn705gvar8b6